Read Time: 2 mins

20/Dynamic high-density functional substrate mapping improves outcomes in ventricular tachycardia ablation

Copy Link
Published Online: Sep 27th 2010 European Journal of Arrhythmia & Electrophysiology. 2020;6(Suppl. 1):abstr20
Authors: NT Srinivasan (Presenting Author) - Barts Heart Centre, St Bartholomew’s Hospital, London; N Papageorgio - Barts Heart Centre, London; J Garcia - Barts Heart Centre, London; G Babu - Bournemouth Hospital, Bournemouth; S Ahsan - Barts Heart Centre, London; RJ Hunter - Barts Heart Centre, London; RJ Schilling - Barts Heart Centre, London; AW Chow - Barts Heart Centre, London; PD Lambiase - Barts Heart Centre, London
Quick Links:
Article Information

Background: The presence of dynamic substrate changes facilitates functional block and re-entry in ventricular tachycardia (VT) but are rarely studied as part of clinical VT mapping. We aimed to compare outcomes of ablation to dynamic functional substrate against standard institutional protocol.

Methods: Thirty patients (age 67 ± 9 yrs, 27 male) with ischemic cardiomyopathy undergoing clinical VT ablation for symptomatic ATP, symptomatic sustained VT or ICD shocks were enrolled form two UK centres. Mean ejection fraction was 25% (± 10%). Mapping was performed with the Advisor™ HD Grid multipolar catheter. A bipolar voltage map was obtained during sinus rhythm (SR) and RV Sensed Protocol (SP) single extra pacing. SP mapping (Figure 1A) involves finding the effective refractory period (ERP) of the single paced RV sensed extra (without a drive train), delivering single sensed extras at 20 ms above RV ERP every 5th beat, templating the morphology of this paced beat, and collecting points that match the template morphology to create a substrate map of this paced beat. SR and SP late potential (LP) and local abnormal ventricular activity (LAVA) maps were made and compared with critical sites for ablation, defined as sites of best entrainment or pace mapping (>96% pacematch), to assess their correlation to these regions. Ablation was then performed to critical sites and LP/LAVA identified by the SP at 50 W for 60 s. The outcomes of SP ablation were then compared to an institutional cohort of 30 patients who underwent historical VT ablation, matched for age and ejection fraction, where ablation was performed by conventional entrainment mapping ± sinus rhythm substrate mapping.

Results: At a median follow up of 12 months 90% of patients were free from symptomatic ATP or ICD shocks vs 60% from the historical institutional VT ablation cohort. Figure 1B shows the pre and post-procedure VT burden during SP VT ablation. SP pacing resulted in a larger area of LP identified for ablation 19.3 mm2 vs  6.4 mm2 during SR mapping (p=0.001), and SP derived LP displayed greater accuracy for critical regions for VT ablation with a true positive predictive value of 87% and false-positive predictive value of 4%, compared with 78% and 35% respectively in SR (Figure 1C). Figure 1D shows the Kaplan-Meier curve of the probability of ICD/CRT-D therapy with SP mapping vs standard institutional protocol. Patients were matched for Age (Age: SP vs Institutional: 67.2 ± 9.0 vs 68.5 ± 5.2, p=NS) and EF (EF: SP vs Institutional: 25.0 ± 9.6 vs 24.4 ± 7.8, p=NS), SP VT ablation resulted in a lower probability of VT(log-rank 0.006).

Conclusion: SP LP/LAVA showed a greater accuracy for critical regions in the VT circuit than sinus rhythm mapping. The combination of ablation to critical sites and SP derived LP/LAVA improved long term outcomes from VT ablation compared to a matched institutional historical cohort of patients who underwent VT ablation.

Further Resources

Share this Article
Related Content In Arrhythmia
  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72